New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
10:00 EDTNFX, LLY, FCX, SNBC, MON, AYI, SPLK, OPEN, INTC, EEP, WSHOn The Fly: Analyst Upgrade Summary
Acuity Brands (AYI) upgraded to Buy from Hold at Canaccord... Eli Lilly (LLY) upgraded to Outperform from Market Perform at Cowen... Intel (INTC) upgraded to Overweight from Neutral at Piper Jaffray... Monsanto (MON) upgraded to Overweight from Neutral at JPMorgan... Newfield Exploration (NFX) upgraded to Buy from Neutral at UBS... OpenTable (OPEN) upgraded to Buy from Neutral at Citigroup... Sun Bancorp (SNBC) upgraded to Neutral from Underperform at Sterne Agee... Willis Group (WSH) upgraded to Buy from Neutral at Nomura... Splunk (SPLK) upgraded to Outperform from Underperform at CLSA... Freeport McMoRan (FCX) upgraded to Outperform from Neutral at Macquarie... Enbridge Energy (EEP) upgraded at Credit Suisse.
News For AYI;LLY;INTC;MON;NFX;OPEN;SNBC;WSH;SPLK;FCX;EEP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
April 8, 2015
20:17 EDTINTCAppeals court questions Google in patent dispute with Microsoft, Reuters says
Subscribe for More Information
11:22 EDTMONOptions with decreasing implied volatility
Subscribe for More Information
11:07 EDTMONOptions with decreasing implied volatility
Subscribe for More Information
08:01 EDTSPLKSplunk awarded contract to support Lockheed Martin's L-35 Lightning II Program
Splunk (SPLK) announced it was awarded a contract to support Lockheed Martinís (LMT) F-35 Lightning II Program. Splunk has provided Lockheed Martin with Splunk Enterprise to monitor and analyze IT systems and network behavior for the Autonomic Logistics Information System, which supports the F-35 Lightning II, a 5th generation fighter jet. Splunk Enterprise is initially being used by Lockheed Martin in 25 different operating environments for IT operations and application delivery, analyzing machine data from the systems and networks supporting the ALIS infrastructure to help ensure applications are operating at peak performance.
April 7, 2015
11:09 EDTMONOptions with decreasing implied volatility
Subscribe for More Information
11:03 EDTWSHWillis Group acquires Carsa Consultores
Willis Group announced it has acquired Carsa Consultores, a broker in Mexico. The move aims to strengthen and support Willis Mexico's existing business, while also expanding its overall footprint, especially in the northwest region of Mexico, creating a new combined network of nine offices nationally.
10:43 EDTSPLKInformatica rises after agreeing to be taken private for $48.75 per share
Subscribe for More Information
10:05 EDTSPLKOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Carnival (CCL) upgraded to Outperform from Market Perform at Wells Fargo... Crown Castle (CCI) upgraded to Buy from Hold at Evercore ISI... Ctrip.com (CTRP) upgraded to Overweight from Neutral at Piper Jaffray... Demandware (DWRE) upgraded to Conviction Buy from Buy at Goldman... FirstEnergy (FE) upgraded at BofA/Merrill... Frontier Communications (FTR) upgraded to Neutral from Underperform at DA Davidson... JPMorgan (JPM) upgraded to Outperform from Market Perform at Bernstein... Pattern Energy (PEGI) upgraded to Outperform from Market Perform at Raymond James... Ralph Lauren (RL) upgraded to Buy from Outperform at CLSA... ResMed (RMD) upgraded to Outperform from Neutral at Credit Suisse... Ryanair (RYAAY) upgraded to Overweight from Neutral at JPMorgan... Splunk (SPLK) upgraded to Overweight from Neutral at Piper Jaffray... Total (TOT) upgraded at RBC Capital... Verifone (PAY) upgraded to Buy from Hold at Stifel... XL Group (XL) upgraded to Buy from Neutral at UBS.
09:57 EDTINTCAltera negotiations with Intel continue, says dealReporter
Subscribe for More Information
08:19 EDTAYIAcuity Brands announces partnership with Key Equipment Finance
Subscribe for More Information
07:14 EDTLLYEyeforpharma to hold a summit
Philadelphia 2015 Commercial Pharma Summit is being held in Philadelphia on April 7-8.
06:40 EDTSPLKSplunk upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Katherine Egbert upgraded Splunk (SPLK) to Overweight saying the stock's valuation is more reasonable following the 13% sell-off since the company's Q4 earnings report. Egbert views Splunk's new distribution agreement with Arrow Electronics (ARW) as a sign of improving demand and she sees the potential for upsell of enterprise-wide license agreements. Shares of the provider of big data products closed yesterday up 95c to $60.18 after analysts at Stephens upgraded the stock Monday morning.
06:38 EDTMONChinese citizens demand to see Monsanto test results, WantChinaTimes says
Subscribe for More Information
April 6, 2015
17:01 EDTINTCIntel to change financial reporting structure
Subscribe for More Information
10:39 EDTINTCQualcomm falls amid uncertainty about content in flagship Samsung phone
Subscribe for More Information
10:33 EDTSPLKFollow-up: Splunk upgraded at Stephens
Subscribe for More Information
10:02 EDTSPLKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:15 EDTSPLKSplunk upgraded to Overweight from Equal Weight at Stephens
Subscribe for More Information
07:14 EDTLLYBiodel GEM device demonstrates 'superior' usability
Biodel (BIOD) announced results from a formative human factors study of its Glucagon Emergency Management, or GEM, device, which is in development for the treatment of diabetes patients experiencing severe hypoglycemia. In the study, the GEM device demonstrated a substantial improvement in ease-of-use and successful delivery of the full dose, as well as a reduction in dosing errors, when compared to commercially available glucagon kits; Eli Lilly's (LLY) Glucagon Emergency Rescue Kit and Novo Nordisk's GlucaGen HypoKit. Furthermore, while training and previous experience increased the success rate with the Eli Lilly and Novo Nordisk glucagon kits, it did not further impact the already high success rate with the GEM device when compared to non-experienced, untrained participants.
April 5, 2015
09:02 EDTMONMonsanto 'deserves a second look', Barron's says
Fears regarding Monsanto seem to be "overdone" and are not related to the stock's fundamentals, Barron's argues in its 'The Trader' column. Long term investors should keep the stock at current levels, the paper adds. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use